Attend PACK EXPO – this year’s can’t-miss event in Chicago, Oct 23-26.
Discover solutions from 2,000+ exhibitors to advance your operations and network with colleagues at PACK EXPO International.
REGISTER TODAY

FDA Approves New MS Treatment

The FDA just gave the green light to a new treatment for multiple sclerosis that decreases the number of patient relapses.

Mavenclad / Image: Social MedWork
Mavenclad / Image: Social MedWork

A recent FDA News Release article noted the FDA’s approval of cladribine tablets that treat relapsing forms of multiple sclerosis. The drug, which goes by the brand name Mavenclad, was approved for EMD Serono, the biopharmaceutical business of Germany-based Merck KgaA.

In a clinical trial conducted with over 1,300 patients, Mavenclad significantly decreased the number of relapses and reduced the progression of disability compared to a placebo.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts